Arbutus Biopharma Corporation (ABUS) News
Track canonical SquawkNews coverage tagged to ABUS, Arbutus Biopharma Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Arbutus Reports Q2 2026 Financial Results
Arbutus reports second quarter 2026 financial results and provides corporate update
EARNINGS | Aug 12, 2026, 11:30 AM UTC
L
ABUS +5% premarket after receiving $178M first payment from MRNA settlement
ABUS +5% premarket after receiving $178M first payment from MRNA settlement
EQUITY | Jul 16, 2026, 11:47 AM UTC
L
ABUS Arbutus initiates international patent infringement enforcement actions against Pfizer and Biontech, receives first payment from Modern
ABUS Arbutus initiates international patent infringement enforcement actions against Pfizer and Biontech, receives first payment from Moderna settlement agreement and announces intent to return capital to shareholders Ar
EQUITY | Jul 16, 2026, 11:31 AM UTC